1. Home
  2. CXDO vs VYGR Comparison

CXDO vs VYGR Comparison

Compare CXDO & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CXDO

Crexendo Inc.

HOLD

Current Price

$6.91

Market Cap

223.1M

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.05

Market Cap

203.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CXDO
VYGR
Founded
1995
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
223.1M
203.6M
IPO Year
1999
2015

Fundamental Metrics

Financial Performance
Metric
CXDO
VYGR
Price
$6.91
$3.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$9.20
$16.50
AVG Volume (30 Days)
457.0K
737.1K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
166.67
N/A
EPS
0.02
N/A
Revenue
$68,167,000.00
$10,135,000.00
Revenue This Year
$45.26
$34.04
Revenue Next Year
$13.31
$7.92
P/E Ratio
$340.50
N/A
Revenue Growth
12.05
N/A
52 Week Low
$5.26
$2.88
52 Week High
$11.23
$5.55

Technical Indicators

Market Signals
Indicator
CXDO
VYGR
Relative Strength Index (RSI) 40.88 38.00
Support Level $6.54 $2.96
Resistance Level $7.02 $4.33
Average True Range (ATR) 0.44 0.17
MACD -0.07 -0.00
Stochastic Oscillator 40.46 13.16

Price Performance

Historical Comparison
CXDO
VYGR

About CXDO Crexendo Inc.

Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support, and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of its revenue from the Cloud telecommunications segment.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: